This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Clinical
Expert analysis: The importance of serological markers and serodiagnostics in RA
Read more
Three in 10 drug-related deaths in acute care due to omitted medicines, research reveals
Read more
New cancer drugs taking longer for NHS patients to access
Read more
Expert view: Ustekinumab for SLE?
Read more
Phase II enrollment for therapeutic vaccine candidate in patients with coeliac disease
Read more
Recommendation to continue ongoing extension study of Phase IIa trial in ulcerative colitis
Read more
Accuracy in predicting patient outcomes in milk oral immunotherapy
Read more
Expert analysis: the importance of testing in Crohn’s disease and colitis
Read more
European Medicines Agency accepts extension MAA for review of Remsima SC
Read more
Research shows that environmental exposures early in life modify immune responses
Read more
Towards a treatment for gluten intolerance
Read more
New study has confirmed the effectiveness of PSA screening in reducing prostate cancer mortality
Read more
A hope for fish allergy sufferers?
Read more
Altering cancer metabolism helps treatments attack tumours
Read more
England lagging behind rest of Europe in cancer survival rates
Read more
NICE gives green light for regorafenib
Read more
Snoring poses a greater cardiac risk to women
Read more
Page 114 of 200
« First
«
...
10
20
30
...
112
113
114
115
116
...
120
130
140
...
»
Last »
Popular articles
Third of patients in favour of AI-supported consultations and clinical documents, study finds
18 April, 2024
Telemedicine strategy post-acute coronary syndrome drives efficiencies and safety, study finds
17 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
x
Search for: